Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Big Pharma’s Gamble On HDL Hypothesis

Apr 23 2012

Related Content

More Disheartening News For Abbott Cholesterol Franchise: Niaspan/Statin Study Halted Due To Lack Of Added Benefit

May 26 2011

Merck Looks Beyond First-In-Class Only As It Seeks To Bolster R&D Productivity

Dec 01 2011

Related Companies

Abbott

Merck & Co., Inc.

US Department of Health and Human Services

University of Illinois System

University of Pennsylvania

Roche Holding AG

Additional Topics

Clinical Trials BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window